Business
NeuroOne Medical Technologies Corporation Appoints Chief Technology Officer
MINNETONKA, MN / ACCESSWIRE / April 15, 2019 /NeuroOne Medical Technologies Corporation (OTCQB:NMTC), a medical technology company focused on improving
About this update from Neuroone Medical Technologies Corporation
[{"type":"text","content":"MINNETONKA, MN / ACCESSWIRE / April 15, 2019 /NeuroOne Medical Technologies Corporation (OTCQB:NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the hiring of Steve Mertens as Chief Technology Officer.\"As we transition from a development-stage company to a commercial entity, I'm looking forward to having Steve as part of our team,\" said NeuroOne's President and CEO Dave Rosa. \"His expertise in medical device development, operations, and quality assurance will be invaluable for us as we further advance our product initiatives.\"Prior to joining NeuroOne, Mertens was Sr. Vice President of R&D and Operations at Nuvaira, a privately held lung denervation company developing minimally invasive products for obstructive lung diseases. Before that, Mertens was a Senior Vice President of Research and Development for Boston Scientific, where he guided a wide range of technologies through product development for the cardiology, electrophysiology, and peripheral vascular markets. Mertens began his medical device career working in engineering, quality control, and manufacturing roles at SciMed Life Sciences. Mertens holds a Bachelor of Science degree in Chemical Engineering from the University of Minnesota and a Master's degree in Business Administration from the University of St. Thomas.\"I am excited to join NeuroOne Medical Technologies team,\" Mertens said. \"I believe our technologies have the potential to become the new gold standard for managing patients worldwide suffering from a variety of neurological conditions.\"About NeuroOneNeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from Epilepsy, Parkinson's Disease, Essential Tremors and other related neurological disorders that may improve patient outcomes and reduce procedural costs.Contact:Dave RosaChief Executive OfficerNeuroOne Medical Technologies [email protected] StatementsThis press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as ...